ProCE Banner Series

Integrating New Data From CROI 2024: Pharmacist Perspectives

Join 2 pharmacist experts for an interactive webinar focused on the most clinically relevant data presented at CROI 2024 and other key studies that may be significant to the advancement of HIV patient care.  Case vignettes will be used to explore integration of findings into everyday patient management.

  ACPE
Who Should Attend

This program is intended for pharmacists, and other healthcare professionals who provide care for people living with or at risk of HIV infection.

All Events

Integrating New Data From CROI 2024: Pharmacist Perspectives

Past Events

March

14

2024

1:00 PM - 2:00 PM Eastern Time (ET)

Virtual

March

28

2024

1:00 PM - 2:00 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Nimish Patel, PharmD, PhD, AAHIVP

Professor of Clinical Pharmacy
Skaggs School of Pharmacy & Pharmaceutical Sciences
University of California, San Diego
La Jolla, California

ProCE Banner Faculty
Samantha Strong, PharmD, BCACP, AAHIVP, CDCES

Clinical Director of Pharmacy
Nevada Health Centers
Las Vegas, Nevada

Topics

The agenda for each webinar is as follows:

  • Introduction and Program Overview
  • Key Findings From CROI 2024
  • Question and Answer Session

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary antiretroviral regimens. 

Target Audience
This program is intended for pharmacists, and other healthcare professionals who provide care for people living with or at risk of HIV infection. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents
  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies
  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC, and the American Academy of HIV Medicine. Clinical Care Options, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-9999-24-025-L02-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC, in partnership with the American Academy of HIV Medicine

Supported by an educational grant from ViiV Healthcare.